Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113582937B details a green isoxazole synthesis using TPGS-750-M. Achieves high purity without heavy metals, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101717428A details a green synthesis of Budesonide using acidic ionic liquids. This report analyzes the technical breakthroughs, cost reduction potential, and supply chain reliability for pharmaceutical manufacturers.
Patent CN100349905C discloses novel Tropp ligands enabling high-efficiency asymmetric hydrogenation. Discover supply chain advantages and technical feasibility.
Patent CN109970659B reveals a green nickel-catalyzed route for benzimidazole and quinazoline intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN106565439B reveals a one-step oxidation method achieving 99.7% purity. This process significantly reduces wastewater and enhances supply chain reliability for global buyers.
Patent CN113292589B reveals a mild SmI2-catalyzed THF ring-opening method. Achieve high yields and cost reduction in fine chemical manufacturing with scalable silane synthesis.
Patent CN104328152A details high-yield biocatalytic synthesis offering supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing.
Advanced manufacturing of L-Phenylephrine HCl using optimized Rh-catalysis for high purity and cost-effective supply chain solutions.
Patent CN108840821A reveals a novel cobalt complex synthesis offering high conversion rates and simplified processes for pharmaceutical intermediate production.
Patent CN115108932A reveals a novel Ru-catalyzed oxidative amidation using DMF. This method offers significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN111635437B reveals a novel palladium catalyst enabling mild, one-pot synthesis of alpha-methylene-gamma-butyrolactones, offering significant cost reduction in fine chemical manufacturing.
Patent CN1898255B details a novel Wittig-HWE route for 4-substituted pyridines, offering cost reduction and scalable manufacturing for agrochemical and pharma intermediates.
Patent CN103012074B reveals a high-yield synthesis method offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing processes globally.
Patent CN108314646B reveals a novel Pd/Ni-MOF catalyst for Apalutamide intermediates, offering high purity, recyclability, and significant cost reduction in API manufacturing.
Patent CN104313073A reveals high-yield biocatalytic route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN112661584A details a mild manganese-catalyzed photocatalytic route for N-alkyl amides, offering significant cost reduction in fine chemical manufacturing and high-purity outputs.
Patent CN102167661A reveals thiazolium salt catalysis for high-yield flavor intermediate production with reduced waste and scalable processes.
Patent CN104263774A reveals high-yield yeast catalysis. Offers supply chain reliability and cost reduction in chiral intermediate manufacturing for global pharma.
High-purity chiral intermediate via black mold catalysis. Scalable production with significant cost and supply chain advantages for global buyers.
Patent CN104313078A reveals high-yield biocatalytic route for chiral thiazole ethanol ensuring supply chain stability and cost efficiency for global pharmaceutical manufacturers.